Moderna says its coronavirus vaccine trial produced 'robust' immune response in all patients

  • 📰 CNBC
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 72%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Moderna's potential vaccine to prevent Covid-19 produced neutralizing antibodies in all 45 patients in its early stage human trial, according to newly released data.

according to newly released data published Tuesday evening in the peer-reviewed New England Journal of Medicine.All 45 patients produced neutralizing antibodies, which scientists believe are important for gaining protection against the virus. In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine.

"These Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost regimen as the optimal dose for the Phase 3 study," Moderna's chief medical officer, Tal Zaks, said in a statement. "We look forward to beginning our Phase 3 study of mRNA-1273 this month to demonstrate our vaccine's ability to significantly reduce the risk of COVID-19 disease.

Moderna said the vaccine was generally well-tolerated, but more than half of the participants reported mild or moderate symptoms such as fatigue, muscle aches or pain at the injection site. The effort by Moderna is one of several working on a potential vaccine for Covid-19, which has infected more than 13 million people and killed at least 573,200 across the globe as of Tuesday, according to data compiled by Johns Hopkins University. More than 100 vaccines are under development globally, according to the World Health Organization.The trial will enroll 30,000 participants across 87 locations, according to ClinicalTrials.gov.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Technology has fuck the WORLD 🌎Up. Uber, Lyft, grub hub, ect. Too much sharing and unnecessary contact. The world need to be reset.

Yup. People got really sick.

Great. But fear porn will reign until the election is over.

$MRNA

Good news , Market should like news

so now we are relying on the company to supply us with efficacy data?

Time tested, Nope not yet, so, YOU are the Test Subject. Congratulations, You're a Modern day Lab Rat, We'll look for a full report in 5 to 10 years. Only the Dumb Asses will be lining up, Let the Dumb ones Die off as most Lab Rats do.

Great news! Better than having no hope for you glass half empty guys.... like Dr. Gottlieb

This is great news!!!

Post this next week when it hasn't ....premature ejaculation from the media as usual🤦🏻‍♂️

Green Day tomorrow 🥳🥳🥳

An experimental vaccine utilizing an experimental delivery technique. What could go wrong?

Just in time for the President’s briefing

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov. At this point in the constant pump train, would they even tell us about severe side effects? When Trump said by the end of the year everybody laughed at him stop hating and start hoping Why does it look like Tesco own brand?
Source: Reuters - 🏆 2. / 97 Read more »